Holen Sie sich die Stockscreener-App
1.835
6.10%
0.115
Schlusskurs vom Vortag:
$1.72
Offen:
$1.72
24-Stunden-Volumen:
230.42K
Relative Volume:
0.31
Marktkapitalisierung:
$129.44M
Einnahmen:
$299.48M
Nettoeinkommen (Verlust:
$-86.45M
KGV:
-1.2233
EPS:
-1.5
Netto-Cashflow:
$-17.32M
1W Leistung:
+1.96%
1M Leistung:
-15.90%
6M Leistung:
-44.70%
1J Leistung:
-59.62%
1-Tages-Spanne:
$1.70
$1.84
1-Wochen-Bereich:
$1.56
$1.845
52-Wochen-Spanne:
$1.56
$5.062
Health Catalyst Inc Stock (HCAT) Company Profile
Firmenname
Health Catalyst Inc
Sektor
Branche
Telefon
801-708-6800
Adresse
10897 SOUTH RIVER FRONT PARKWAY, #300, SOUTH JORDAN
Compare HCAT vs VEEV, TEM, BTSG, HQY, WAY
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HCAT
Health Catalyst Inc
|
1.83 | 121.66M | 299.48M | -86.45M | -17.32M | -1.50 |
|
VEEV
Veeva Systems Inc
|
185.71 | 30.56B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
52.10 | 9.19B | 1.27B | -245.03M | -245.36M | -1.4071 |
|
BTSG
Brightspring Health Services Inc
|
41.64 | 7.33B | 11.99B | 24.18M | 234.31M | 0.2956 |
|
HQY
Healthequity Inc
|
82.45 | 6.87B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
26.43 | 5.09B | 906.14M | -52.62M | 89.62M | -0.3621 |
Health Catalyst Inc Stock (HCAT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-27 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2025-08-11 | Herabstufung | Citigroup | Buy → Neutral |
| 2025-08-08 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2025-06-17 | Herabstufung | BTIG Research | Buy → Neutral |
| 2025-04-09 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2025-01-08 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2024-04-10 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2024-01-03 | Eingeleitet | Barclays | Overweight |
| 2024-01-03 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2023-12-13 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2023-11-13 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2023-08-01 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-05-10 | Herabstufung | Guggenheim | Buy → Neutral |
| 2023-05-10 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2023-04-20 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2023-04-12 | Eingeleitet | Stephens | Equal-Weight |
| 2023-04-04 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-01-03 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2022-10-31 | Eingeleitet | Wells Fargo | Equal Weight |
| 2022-10-25 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-09-16 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2022-09-13 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2022-08-05 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2022-08-05 | Herabstufung | Stifel | Buy → Hold |
| 2022-04-14 | Eingeleitet | Guggenheim | Buy |
| 2022-03-17 | Hochstufung | Jefferies | Hold → Buy |
| 2022-02-11 | Eingeleitet | Goldman | Buy |
| 2021-12-02 | Eingeleitet | Jefferies | Hold |
| 2021-10-14 | Eingeleitet | BTIG Research | Buy |
| 2021-04-29 | Fortgesetzt | JP Morgan | Overweight |
| 2020-12-08 | Eingeleitet | Berenberg | Buy |
| 2020-07-14 | Eingeleitet | Citigroup | Buy |
| 2020-06-18 | Eingeleitet | Stifel | Buy |
| 2020-06-15 | Fortgesetzt | Evercore ISI | Outperform |
| 2020-05-15 | Eingeleitet | Guggenheim | Buy |
| 2020-04-21 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2020-04-13 | Eingeleitet | SVB Leerink | Outperform |
| 2020-04-02 | Eingeleitet | Canaccord Genuity | Buy |
| 2019-12-20 | Eingeleitet | Raymond James | Strong Buy |
| 2019-10-30 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2019-08-19 | Eingeleitet | Evercore ISI | Outperform |
| 2019-08-19 | Eingeleitet | Goldman | Buy |
| 2019-08-19 | Eingeleitet | JP Morgan | Overweight |
| 2019-08-19 | Eingeleitet | Piper Jaffray | Overweight |
| 2019-08-19 | Eingeleitet | SVB Leerink | Outperform |
| 2019-08-19 | Eingeleitet | SunTrust | Buy |
| 2019-08-19 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Health Catalyst Inc Aktie (HCAT) Neueste Nachrichten
Benjamin Albert notifies sale of 4,966 restricted HCAT shares (NASDAQ: HCAT) - Stock Titan
Bentley Systems, Guidewire Software, Health Catalyst, and Doximity Shares Skyrocket, What You Need To Know - Finviz
Health Catalyst to Announce Fourth Quarter and Year End 2025 Operating Results and Host Conference Call on Thursday, March 12, 2026 - Bitget
How to listen to Health Catalyst’s March 12 results call - Stock Titan
Value Recap: Does Health Catalyst Inc outperform in volatile marketsMarket Activity Report & Capital Protection Trade Alerts - baoquankhu1.vn
Revenue per share of Health Catalyst, Inc. – DUS:2YP - TradingView
Primecap Management Co. CA Sells 617,620 Shares of Health Catalyst, Inc. $HCAT - MarketBeat
Health Catalyst (HCAT) CEO logs large RSU grants and tax-driven share sale - Stock Titan
Health Catalyst (NASDAQ: HCAT) CPO gets RSU, PRSU grants and tax sell-to-cover - Stock Titan
Large stock grants and tax-driven share sale at Health Catalyst (HCAT) - Stock Titan
FOMO Trade: Should I set a stop loss on Health Catalyst Inc2025 Biggest Moves & Safe Entry Zone Identification - baoquankhu1.vn
Health Catalyst (NASDAQ: HCAT) director plans sale of 6,614 shares - Stock Titan
Health Catalyst (HCAT) insider sale notice: 4,471 shares via Morgan Stanley - Stock Titan
Health Catalyst (NASDAQ: HCAT) exec to sell 28,875 restricted shares via MS - Stock Titan
Health Catalyst, Inc (HCAT) Stock Analysis: Potential Upside of 116% Piques Investor Interest - DirectorsTalk Interviews
HCAT PE Ratio & Valuation, Is HCAT Overvalued - Intellectia AI
How The Health Catalyst (HCAT) Story Is Shifting After Target Cut And CEO Transition - Yahoo Finance
Whetstone Capital Advisors, LLC Increases Stake in Health Cataly - GuruFocus
HCAT Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Health Catalyst Names New CEO Amid Board Restructuring - TipRanks
What are Health Catalyst Inc.’s recent SEC filings showingPortfolio Return Summary & Low Drawdown Investment Ideas - mfd.ru
Health Catalyst Inc expected to post earnings of 9 cents a shareEarnings Preview - TradingView
Health Catalyst, Inc (HCAT) Stock Analysis: Exploring the 118.93% Potential Upside for Opportunistic Investors - DirectorsTalk Interviews
Health Catalyst appoints Ben Albert as CEO - TipRanks
Health Catalyst appoints Ben Albert as CEO, plans to reduce board size - Investing.com Nigeria
Health Catalyst (HCAT) Restructures Board Leadership - GuruFocus
Health Catalyst names new CEO; downsizes board (HCAT:NASDAQ) - Seeking Alpha
Health Catalyst, Inc. Announces Appointment of Ben Albert as Chief Executive Officer, Effective February 12, 2026 - marketscreener.com
Health Catalyst Appoints Ben Albert as Chief Executive Officer - Finviz
Health Catalyst names Ben Albert CEO as Daniel Burton accelerates retirement - TradingView
Health Catalyst (HCAT) to Release Earnings on Wednesday - MarketBeat
Health Catalyst, Inc. (NASDAQ:HCAT) Receives Average Recommendation of "Hold" from Brokerages - MarketBeat
Health Catalyst (NASDAQ:HCAT) Trading Down 6%Time to Sell? - MarketBeat
Zoom, Akamai Technologies, Health Catalyst, SentinelOne, and PubMatic Stocks Trade Down, What You Need To Know - The Globe and Mail
Aug Closing: Does Health Catalyst Inc. have a sustainable dividendJuly 2025 Sector Moves & Stepwise Trade Signal Implementation - mfd.ru
Down 20.4% in 4 Weeks, Here's Why Health Catalyst (HCAT) Looks Ripe for a Turnaround - Finviz
Rally Mode: Does Health Catalyst Inc outperform in volatile marketsBull Run & Safe Entry Momentum Tips - baoquankhu1.vn
Why analysts recommend Health Catalyst Inc. (2YP) stockJuly 2025 Momentum & Capital Protection Trade Alerts - mfd.ru
Down 21.4% in 4 Weeks, Here's Why Health Catalyst (HCAT) Looks Ripe for a Turnaround - Finviz
Risk On: How Health Catalyst Inc. stock reacts to job market dataTrade Analysis Report & Weekly Breakout Stock Alerts - mfd.ru
Improved Revenues Required Before Health Catalyst, Inc. (NASDAQ:HCAT) Shares Find Their Feet - simplywall.st
Why Health Catalyst Inc. stock is considered a top pickPortfolio Performance Summary & Daily Chart Pattern Signal Reports - mfd.ru
Health Catalyst and F5 Stocks Trade Down, What You Need To Know - Finviz
Health Catalyst, Inc (HCAT) Stock Analysis: Exploring A Potential Upside Of Nearly 95% - DirectorsTalk Interviews
3 Cash-Burning Stocks Walking a Fine Line - Finviz
Will Health Catalyst Inc. stock maintain growth storyJuly 2025 Intraday Action & Stepwise Swing Trade Plans - mfd.ru
Health Catalyst leverages AI to enhance clinical outcomes - Traders Union
What drives Health Catalyst Incs stock priceTrade Performance Summary & Weekly Stock Breakout Alerts - baoquankhu1.vn
Best Places to Work 2025 - Modern Healthcare
3 of Wall Street's Favorite Stocks We Approach with Caution - Finviz
Marquis Who's Who Honors Kristin Acree for Expertise in Public Health - lelezard.com
Finanzdaten der Health Catalyst Inc-Aktie (HCAT)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.87%
0.50%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):